help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 19, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0447
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/9/3458    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vorona, E.
Right arrow Articles by Nieschlag, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vorona, E.
Right arrow Articles by Nieschlag, E.
Related Collections
Right arrow Male Endocrinology

Submitted on February 27, 2007
Accepted on June 11, 2007

Clinical, endocrinologic and epigenetic features of the 46, XX male syndrome compared to 47,XXY Klinefelter patients

Elena Vorona, Michael Zitzmann, Jörg Gromoll, Andreas N. Schüring, and Eberhard Nieschlag*

Institute of Reproductive Medicine of the University and Clinic and Policlinic for Obstetrics and Gynecology, Münster, Germany

* To whom correspondence should be addressed. E-mail: eberhard.nieschlag{at}ukmuenster.de.

CONTEXT The 46,XX male syndrome represents a rare, poorly characterised form of male hypogonadism.

OBJECTIVE To distinguish the 46,XX male syndrome from the more frequent 47,XXY-Klinefelter syndrome in regard to clinical, hormonal and epigenetic features.

DESIGN Case-control study.

SETTING University-based reproductive medicine and andrology institution.

PATIENTS 11 SRY-positive 46,XX males were compared to age-matched controls: 101 47,XXY Klinefelter patients, 78 healthy men and 157 healthy women (latter all heterozygous for androgen receptor [AR] alleles).

INTERVENTIONS None.

MAIN OUTCOME MEASURES Comparison of phenotype, endocrine profiles and X-chromosomal inactivation patterns of AR alleles.

RESULTS The 46,XX males were significantly smaller than Klinefelter patients or healthy men, resembling female controls in height and weight. The incidence of maldescended testes was significantly higher than that in Klinefelter patients and controls. Gynecomastia was more frequent in comparison to controls, while there was a non-significant trend in comparison to Klinefelter patients. All XX males were infertile and most were hypogonadal. The inactivation patterns of AR alleles in XX males were significantly more skewed than in Klinefelter patients and women. Seven of ten heterozygous XX male patients displayed an extreme skewing of >80% with no preference towards the shorter or longer AR allele. The length of the AR CAG repeat polymorphism was positively related to traits of hypogonadism.

CONCLUSIONS XX males are distinctly different from Klinefelter patients in terms of clinical and epigenetic features. Non-random X chromosome inactivation ratios are common in XX males, possibly due to the translocated SRY gene. The existence of a Y-chromosomal, growth-related gene is discussed.


Key words: Epigenetics • Hypogonadism • Testosterone • Androgen Receptor




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
L. Aksglaede, R. B. Jensen, E. Carlsen, P. Kok, D. M Keenan, J. Veldhuis, N. E Skakkebaek, and A. Juul
Increased basal and pulsatile secretion of FSH and LH in young men with 47,XXY or 46,XX karyotypes.
Eur. J. Endocrinol., June 1, 2008; 158(6): 803 - 810.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Aksglaede, N. E. Skakkebaek, and A. Juul
Abnormal Sex Chromosome Constitution and Longitudinal Growth: Serum Levels of Insulin-Like Growth Factor (IGF)-I, IGF Binding Protein-3, Luteinizing Hormone, and Testosterone in 109 Males with 47,XXY, 47,XYY, or Sex-Determining Region of the Y Chromosome (SRY)-Positive 46,XX Karyotypes
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 169 - 176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society